Opportunity ID: 263416

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AG-15-011
Funding Opportunity Title: Biomarkers of Alzheimers Disease in Down Syndrome (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.865 — Child Health and Human Development Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Aug 28, 2014
Last Updated Date:
Original Closing Date for Applications: Jan 12, 2015
Current Closing Date for Applications: Jan 12, 2015
Archive Date: Feb 12, 2015
Estimated Total Program Funding: $5,000,000
Award Ceiling: $2,500,000
Award Floor:

Eligibility

Eligible Applicants: State governments
Public housing authorities/Indian housing authorities
For profit organizations other than small businesses
City or township governments
Private institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Independent school districts
Native American tribal governments (Federally recognized)
Special district governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public and State controlled institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The goal of this funding opportunity announcement is to enable the identification of the longitudinal progression of Alzheimer’s disease in adults with Down Syndrome using clinical, cognitive, imaging, genetic and biochemical biomarkers.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-15-011.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-C FORMS-C PKG00204609 Dec 12, 2014 Jan 12, 2015 View

Package 1

Mandatory forms

263416 RR_SF424_2_0-2.0.pdf

263416 PHS398_ResearchPlan_2_0-2.0.pdf

263416 PHS398_CoverPageSupplement_2_0-2.0.pdf

263416 RR_KeyPersonExpanded_2_0-2.0.pdf

263416 RR_OtherProjectInfo_1_3-1.3.pdf

263416 PerformanceSite_2_0-2.0.pdf

Optional forms

263416 RR_SubawardBudget30_1_3-1.3.pdf

263416 PlannedReport-1.0.pdf

263416 PHS398_CumulativeInclusionReport-1.0.pdf

263416 PHS398_ModularBudget_1_2-1.2.pdf

263416 RR_Budget_1_3-1.3.pdf

2025-07-09T17:16:20-05:00

Share This Post, Choose Your Platform!

About the Author: